What is the level of liabilities of Catalent this year?
Catalent has a debt balance of 6.17 B USD this year.
Catalent Liabilities 2024
Catalent Liabilities
6.17 B USD
Catalent Dividend yield
Ticker
CTLT
ISIN
US1488061029
WKN
A112H2
In 2024, Catalent's total liabilities amounted to 6.17 B USD, a 7.95% difference from the 5.71 B USD total liabilities in the previous year.
Catalent Aktienanalyse
What does Catalent do?
Catalent Inc is a global leader in advanced active ingredients and medical products, as well as solutions for drug development and manufacturing. The company was founded in 1933 by the Schering brothers in the USA and has become one of the preferred partners in the pharmaceutical industry due to its innovation, flexibility, and reliability. Catalent's business model is based on providing high-quality services and products that contribute to improving human health. The company offers a wide range of solutions, from active ingredient development to drug formulation and manufacturing, clinical trials, and product packaging. Through this comprehensive offering, Catalent helps its customers accelerate their drug development and product launch. The company is divided into different business sectors with specialized solutions, including the manufacturing of biopharmaceuticals such as antibodies, cell therapies, and vaccines, as well as medical devices, active ingredient manufacturing, and pharmaceutical development and manufacturing. Catalent's services also include active ingredient development, assisting customers in all stages of drug development from identifying new active ingredients to optimizing production processes. The company specializes in formulating drugs into suitable delivery forms that ensure safe and effective use, offering a variety of oral, inhalable, and parenteral formulations. Catalent also provides clinical trials, testing the efficacy and safety of drugs in clinical trials. The company has state-of-the-art facilities and expertise to professionally and successfully support its customers in conducting clinical studies. Additionally, Catalent offers a wide range of packaging solutions, including glass bottles, plastic containers, aluminum tubes, and the finishing and packaging of finished drugs. The company has advanced production systems that enable quick and flexible packaging production in any desired size and shape. Overall, Catalent provides its customers with a comprehensive range of services and products that enable fast and effective drug development and market launch. The company's strong innovation and diverse range of expertise make it a preferred partner in the pharmaceutical industry. Catalent ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Catalent's Liabilities
Catalent's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Catalent's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Catalent's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Catalent's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Catalent’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Catalent Stock
What were the liabilities of Catalent compared to the previous year?
The liabilities of Catalent have increased by 7.95% increased compared to the previous year.
What are the consequences of high debt for investors of Catalent?
High liabilities can pose a risk for investors of Catalent, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Catalent?
Low liabilities mean that Catalent has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Catalent affect the company?
An increase in liabilities of Catalent can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Catalent affect the company?
A decrease in the liabilities of Catalent can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Catalent?
Some factors that can influence the liabilities of Catalent include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Catalent so important for investors?
The liabilities of Catalent are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Catalent take to modify the liabilities?
To change its liabilities, Catalent can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Catalent pay?
Over the past 12 months, Catalent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Catalent is expected to pay a dividend of 0 USD.
What is the dividend yield of Catalent?
The current dividend yield of Catalent is .
When does Catalent pay dividends?
Catalent pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Catalent?
Catalent paid dividends every year for the past 0 years.
What is the dividend of Catalent?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Catalent located?
Catalent is assigned to the 'Health' sector.
Wann musste ich die Aktien von Catalent kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Catalent from 4/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.
When did Catalent pay the last dividend?
The last dividend was paid out on 4/29/2024.
What was the dividend of Catalent in the year 2023?
In the year 2023, Catalent distributed 0 USD as dividends.
In which currency does Catalent pay out the dividend?
The dividends of Catalent are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Catalent stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Catalent
Our stock analysis for Catalent Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Catalent Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
